|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4365 | |
| A61K 31/44 | |||
| A61K 45/06 | |||
| A61P 7/02 | |||
| A61P 9/10 |
| (11) | Patento numeris | 2155195 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08742820.7 |
| Europos patento paraiškos padavimo data | 2008-04-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-02-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/004760 |
| Data | 2008-04-11 |
| (87) | Numeris | WO 2008/127682 |
| Data | 2008-10-23 |
| (30) | Numeris | Data | Šalis |
| 911852 P | 2007-04-13 | US |
| (72) |
SINHA, Uma, US
HOLLENBACH, Stanley, J., US
ANDRE, Patrick, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
| Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |